Ferroelectric nematic composition and device thereof

Abstract

Provided herein are ferroelectric nematic (N.sub.F) compositions comprising a ferroelectric nematic host and one or more nonlinear optical compounds (chromophores).

Claims

1. A ferroelectric nematic (N.sub.F) composition comprising a ferroelectric nematic host and a nonlinear optical compound having a formula of: D-B-A, wherein D is a donor moiety, B is a -conjugated bridging moiety, and A is an acceptor moiety; wherein the second order nonlinear optical (NLO) coefficient of the nonlinear optical compound is higher than the NLO coefficient of the N.sub.F host.

2. The ferroelectric nematic composition of claim 1, wherein the spontaneous polarization (Ps) of the ferroelectric nematic composition is greater than about 1 C/cm{circumflex over ()}2.

3. The ferroelectric nematic composition of claim 1, wherein the NLO coefficient of the N.sub.F host is greater than 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, or 1 pm/V.

4. The ferroelectric nematic composition of claim 1, wherein the N.sub.F host comprises a compound of Formula (I): ##STR00176## wherein ring A, ring B, and each ring C are independently an aryl; L.sup.A and each L.sup.B are each independently a bond, NN, or ##STR00177## wherein R.sup.3 and R.sup.4 are each fluoro or R.sup.3 and R.sup.4 form an oxo; R.sup.1 and R.sup.2 are each independently hydrogen, fluoro, or C.sub.1-6 alkoxy; R.sup.A1 is hydrogen, C.sub.1-6 alkyl, C.sub.1-6 alkoxy, C.sub.1-6 heteroalkyl, or ##STR00178## wherein R.sup.A4 is C.sub.1-6 alkyl; R.sup.A2 and R.sup.A3 are each independently hydrogen, fluoro, or OR, wherein R is C.sub.1-6 alkyl optionally substituted with a C.sub.1-6 alkoxy; R.sup.B1 is fluoro, NO.sub.2, or CN; R.sup.B2 and R.sup.B3 are each independently hydrogen, fluoro, or methoxy; and n is an integer of 1 to 8; provided at least one of L.sup.A and L.sup.B is not a bond.

5. The ferroelectric nematic composition of claim 4, wherein the compound of Formula (I) has a structure of Formula (Ia): ##STR00179##

6. The ferroelectric nematic composition of claim 4, wherein ##STR00180## R.sup.A1 is C.sub.1-6 alkyl or ##STR00181## R.sup.X is C.sub.1-6 alkyl and R.sup.Y is C.sub.1-6 alkyl optionally substituted with methoxy; wherein ##STR00182## is optionally ##STR00183## R.sup.B2 is hydrogen or fluoro, and R.sup.B1 is CN or F.

7. The ferroelectric nematic composition of claim 4, wherein the compound of Formula (I) comprises: ##STR00184## ##STR00185## ##STR00186##

8. The ferroelectric nematic composition of claim 1, wherein the nonlinear optical compound has a neutral ground state.

9. The ferroelectric nematic composition of claim 1, wherein in the nonlinear optical compound of Formula D-B-A, D is ##STR00187## wherein Ring A is an aryl, heterocyclyl, or heteroaryl ring, each Y.sup.1 is independently-OH, fluoro, NR.sup.5R.sup.6, C.sub.1-8 cycloalkyl, or C.sub.1-6 alkoxy, wherein R.sup.5 and R.sup.6 are each independently hydrogen or C.sub.1-6 alkyl; p is an integer of 0 to 5.

10. The ferroelectric nematic composition of claim 9, wherein in the nonlinear optical compound of Formula D-B-A, B is selected from: a bond, ##STR00188## and a combination thereof; wherein each Y is independently N or CH, each Z is independently hydrogen, fluoro, chloro, or C.sub.1-6 alkoxy, W is hydrogen, fluoro, chloro, C.sub.1-8 alkyl, C.sub.1-8 alkoxy, C.sub.1-8 heteroalkyl, or C.sub.1-8 haloalkyl, q is an integer of 0 to 5, and t is an integer of 1 to 5.

11. The ferroelectric nematic composition of claim 9, wherein B is selected from: a bond, ##STR00189##

12. The ferroelectric nematic composition of claim 9, wherein in the nonlinear optical compound of Formula D-B-A, A is selected from: ##STR00190## wherein each Y.sup.2 is hydrogen, fluoro, chloro, NO.sub.2, CN, NCS, SO.sub.2CH.sub.3, or SO.sub.2CF.sub.3; each Y.sup.3 is independently hydrogen, fluoro, chloro, C.sub.1-8 alkyl, C.sub.1-8 alkoxy, C.sub.1-8 heteroalkyl, or C.sub.1-8 haloalkyl; R.sup.7, R.sup.8, and R.sup.9 are each independently hydrogen or CN, and at least one of R.sup.7, R.sup.8, and R.sup.9 is CN.

13. The ferroelectric nematic composition of claim 12, wherein A is selected from: ##STR00191##

14. The ferroelectric nematic composition of claim 1, wherein D is selected from: ##STR00192## wherein R.sup.5, R.sup.6 and R.sup.9 are each independently hydrogen or C.sub.1-6 alkyl, R.sup.7 and R.sup.8 are each independently hydrogen or C.sub.1-6 alkoxy, and R.sup.12 is hydrogen, C.sub.1-10 alkyl, C.sub.1-10 heteroalkyl, OC.sub.1-10 alkyl, OC.sub.1-10 heteroalkyl, OC.sub.0-9 alkylene-C.sub.6-10 aryl, OC.sub.0-9 alkylene-C.sub.1-10 heteroaryl, or NR.sup.5R.sup.6, wherein D is optionally ##STR00193##

15. The ferroelectric nematic composition of claim 1, wherein the nonlinear optical compound has a zwitterionic ground state.

16. The ferroelectric nematic composition of claim 1, wherein the nonlinear optical compound is selected from the group consisting of: ##STR00194## ##STR00195## ##STR00196##

17. The ferroelectric nematic composition of claim 1, wherein the ferroelectric nematic (N.sub.F) composition comprises between about 1% to about 30% w/w nonlinear optical compound(s).

18. A device comprising the ferroelectric nematic composition of claim 1.

19. The device of claim 18, wherein the device comprises two or more electrodes.

20. The device of claim 19, an electric field is applied between the electrodes and across the ferroelectric nematic composition within the device.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

(1) Various aspects of the disclosure are set forth with particularity in the appended claims. A better understanding of the features and advantages of the present disclosure will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the disclosure are utilized, and the accompanying drawings.

(2) FIG. 1 illustrates an absorption spectrum of a ferroelectric nematic (N.sub.F) composition in a 2 um parallel buffed sandwich cell, in accordance with some embodiments.

(3) FIG. 2 illustrates a measurement of the electro-optic coefficient (r.sub.33) of a ferroelectric nematic (N.sub.F) composition, with and without a non-linear optical (NLO) dye, in accordance with some embodiments.

DETAILED DESCRIPTION

(4) Ferroelectric Nematic (N.sub.F) Compositions

(5) In one aspect, provided herein are ferroelectric nematic (N.sub.F) compositions comprising a ferroelectric nematic host and one or more nonlinear optical compounds (chromophores). In certain embodiments, the nonlinear optical compound has a Formula of: D-B-A, wherein D is a donor moiety, B is a x-conjugated bridging moiety, and A is an acceptor moiety

(6) In some embodiments, the second order nonlinear optical (NLO) coefficient of the N.sub.F host is greater than 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, or 1 pm/V. In some embodiments, the NLO coefficient of the N.sub.F host is greater than 1 pm/V. In some embodiments, the NLO coefficient of the N.sub.F host is greater than 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20 pm/V. In some embodiments, the NLO coefficient of the N.sub.F host is greater than 5, 10, 15, 20, 25, 30, 35, 40, 45, or 50 pm/V.

(7) In some embodiments, the second order nonlinear optical (NLO) coefficient (.sup.(2)) of the nonlinear optical compound is higher than the NLO coefficient of the N.sub.F host. In some embodiments, the second order NLO coefficient (.sup.(2)) of the nonlinear optical compound is greater than 1, 2, 3, 4, 5, 10, 20, 30, 40, 50, 100, or 200 pm/V. In some embodiments, the second order NLO coefficient (.sup.(2)) of the nonlinear optical compound is greater than 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 pm/V. In some embodiments, the second order NLO coefficient (.sup.(2)) of the nonlinear optical compound is greater than 10, 20, 30, 40, 50, 60, 70, 80, 90, or 100 pm/V. In some embodiments, the .sup.(2) is greater than 100 pm/V. In some embodiments, the .sup.(2) is greater than 200 pm/V.

(8) In some embodiments, the spontaneous polarization (Ps) of the ferroelectric nematic composition is greater than about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 20, 30, 40, 50, 60, 70, 80, 90, or 100 C/cm{circumflex over ()}2. In some embodiments, the spontaneous polarization (Ps) of the ferroelectric nematic composition is greater than about 1 C/cm{circumflex over ()}2. In some embodiments, the spontaneous polarization (Ps) of the ferroelectric nematic composition is greater than about 10 C/cm{circumflex over ()}2. In some embodiments, the spontaneous polarization (Ps) of the ferroelectric nematic composition is between about 1 to about 100 C/cm{circumflex over ()}2, about 5 to about 100 C/cm{circumflex over ()}2, about 10 to about 100 C/cm{circumflex over ()}2, about 20 to about 100 C/cm{circumflex over ()}2, about 30 to about 100 C/cm{circumflex over ()}2, about 40 to about 100 C/cm{circumflex over ()}2 or about 50 to about 100 C/cm{circumflex over ()}2. In one embodiment, the spontaneous polarization (Ps) of the ferroelectric nematic composition is between about 1 to about 10 C/cm{circumflex over ()}2. In one embodiment, the spontaneous polarization (Ps) of the ferroelectric nematic composition is between about 1 to about 9 C/cm{circumflex over ()}2. In one embodiment, the spontaneous polarization (Ps) of the ferroelectric nematic composition is between about 1 to about 8 C/cm{circumflex over ()}2. In one embodiment, the spontaneous polarization (Ps) of the ferroelectric nematic composition is between about 1 to about 7 C/cm{circumflex over ()}2. In one embodiment, the spontaneous polarization (Ps) of the ferroelectric nematic composition is between about 1 to about 6 C/cm{circumflex over ()}2. In one embodiment, the spontaneous polarization (Ps) of the ferroelectric nematic composition is between about 1 to about 5 C/cm{circumflex over ()}2. In one embodiment, the spontaneous polarization (Ps) of the ferroelectric nematic composition is between about 1 to about 4 C/cm{circumflex over ()}2. In one embodiment, the spontaneous polarization (Ps) of the ferroelectric nematic composition is between about 1 to about 3 C/cm{circumflex over ()}2. In one embodiment, the spontaneous polarization (Ps) of the ferroelectric nematic composition is between about 3 to about 10 C/cm{circumflex over ()}2. In one embodiment, the spontaneous polarization (Ps) of the ferroelectric nematic composition is between about 3 to about 20 C/cm{circumflex over ()}2. In one embodiment, the spontaneous polarization (Ps) of the ferroelectric nematic composition is between about 3 to about 30 C/cm{circumflex over ()}2.

(9) In some embodiments, the N.sub.F host has a dielectric permittivity constant greater than about 1000, 2000, 3000, 4000, 5000, 6000, 7000, 8000, 9000, or 10000. In some embodiments, the N.sub.F host has a dielectric permittivity constant greater than about 1000, 2000, 3000, 4000, 5000, 6000, 7000, 8000, 9000, or 10000 at a frequency between 1 and 10 kHz. In some embodiments, the N.sub.F host has a dielectric permittivity constant greater than about 1000, 2000, 3000, 4000, 5000, 6000, 7000, 8000, 9000, or 10000 at any frequency between 1 and 10 kHz. In some embodiments, the N.sub.F host has a dielectric permittivity constant greater than about 1000, 2000, 3000, 4000, 5000, 6000, 7000, 8000, 9000, or 10000 at a frequency between 1 and 10 KHz. In some embodiments, the N.sub.F host has a dielectric permittivity constant greater than about 10000 at a frequency between 1 and 10 kHz. In some embodiments, the N.sub.F host has a dielectric permittivity constant greater than about 10000 at any frequency between 1 and 10 KHz.

(10) In some embodiments, the N.sub.F host has a dipole moment () greater than about 5 D, 6 D, 7 D, 8 D, 9 D, or 10 D. In some embodiments, the N.sub.F host has a dipole moment () great than about 5 D. In some embodiments, the N.sub.F host has a dipole moment () great than about 6 D. In some embodiments, the N.sub.F host has a dipole moment () greater than about 7 D. In some embodiments, the N.sub.F host has a dipole moment () greater than about 8 D. In some embodiments, the N.sub.F host has a dipole moment () greater than about 9 D. In some embodiments, the N.sub.F host has a dipole moment (u) greater than about 10 D. In some embodiments, the N.sub.F host has a dipole moment () greater than about 11 D, 12 D, 13 D, 14 D, 15 D, 16 D, 17 D, 18 D, 19 D, 20 D, 25 D, 30 D, 35 D, 40 D, or 45 D. In some embodiments, the N.sub.F host has a dipole moment () between about 8 D and about 50 D. In some embodiments, the N.sub.F host has a dipole moment of between about 8 D and about 50 D. In some embodiments, the N.sub.F host has a dipole moment of between about 8 D and about 50 D. In some embodiments, the N.sub.F host has a dipole moment of between about 8 D and about 40 D. In some embodiments, the N.sub.F host has a dipole moment of between about 8 D and about 30 D. In some embodiments, the N.sub.F host has a dipole moment of between about 8 D and about 20 D. In some embodiments, the N.sub.F host has a dipole moment of between about 8 D and about 10 D. In some embodiments, the N.sub.F host has a dipole moment of between about 10 D and about 50 D. In some embodiments, the N.sub.F host has a dipole moment of between about 10 D and about 40 D. In some embodiments, the N.sub.F host has a dipole moment of between about 10 D and about 30 D. In some embodiments, the N.sub.F host has a dipole moment of between about 10 D and about 20 D. In some embodiments, the N.sub.F host has a dipole moment of between about 15 D and about 50 D. In some embodiments, the N.sub.F host has a dipole moment of between about 15 D and about 40 D. In some embodiments, the N.sub.F host has a dipole moment of between about 15 D and about 30 D. In some embodiments, the N.sub.F host has a dipole moment of between about 15 D and about 20 D. In some embodiments, the N.sub.F host has a dipole moment of between about 20 D and about 50 D. In some embodiments, the N.sub.F host has a dipole moment of between about 20 D and about 40 D. In some embodiments, the N.sub.F host has a dipole moment of between about 20 D and about 30 D.

(11) In some embodiments, ferroelectric nematic (N.sub.F) composition comprises about 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%, or 30% w/w nonlinear optical compound(s). In some embodiments, ferroelectric nematic (N.sub.F) composition comprises between about 1% to about 5% w/w nonlinear optical compound(s). In some embodiments, ferroelectric nematic (N.sub.F) composition comprises between about 1% to about 10% w/w nonlinear optical compound(s). In some embodiments, ferroelectric nematic (N.sub.F) composition comprises between about 1% to about 15% w/w nonlinear optical compound(s). In some embodiments, ferroelectric nematic (N.sub.F) composition comprises between about 1% to about 20% w/w nonlinear optical compound(s). In some embodiments, ferroelectric nematic (N.sub.F) composition comprises between about 1% to about 25% w/w nonlinear optical compound(s). In some embodiments, ferroelectric nematic (N.sub.F) composition comprises between about 1% to about 30% w/w nonlinear optical compound(s). In some embodiments, ferroelectric nematic (N.sub.F) composition comprises between about 1% to about 40% w/w nonlinear optical compound(s). In some embodiments, ferroelectric nematic (N.sub.F) composition comprises between about 1% to about 50% w/w nonlinear optical compound(s).

(12) By employing nonlinear optical compound(s), the nonlinear optical property of the N.sub.F host is improved without significant deterioration of the dielectric permissivity constant . A material containing such a nonlinear optical compound exhibiting a larger nonlinear optical effect can give a nonlinear optical element that can change the intensity and phase of light in response to even a weaker external field applied thereto. In some embodiments, the NLO coefficient of the N.sub.F composition is about 5%, 10%, 15%, 20%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 100% greater than the NLO coefficient of the N.sub.F host. In some embodiments, the NLO coefficient of the N.sub.F composition is about 25%, 50%, 75%, 100%, 150%, or 200% greater than the NLO coefficient of the N.sub.F host.

(13) As used herein and in the appended claims, the singular forms a, and, and the include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to an agent includes a plurality of such agents, and reference to the cell includes reference to one or more cells (or to a plurality of cells) and equivalents thereof known to those skilled in the art, and so forth. When ranges are used herein for physical properties, such as molecular weight, or chemical properties, such as chemical formulae, all combinations and subcombinations of ranges and specific embodiments therein are intended to be included. The term about when referring to a number or a numerical range means that the number or numerical range referred to is an approximation within experimental variability (or within statistical experimental error), and thus the number or numerical range, in some instances, will vary between 1% and 15% of the stated number or numerical range. In some embodiments, about is within 10% of the stated number or numerical range. In some embodiments, about is within 5% of the stated number or numerical range. In some embodiments, about is within 1% of the stated number or numerical range. The term comprising (and related terms such as comprise or comprises or having or including) is not intended to exclude that in other certain embodiments, for example, an embodiment of any composition of matter, composition, method, or process, or the like, described herein, consist of or consist essentially of the described features.

Definitions

(14) As used in the specification and appended claims, unless specified to the contrary, the following terms have the meaning indicated below.

(15) Alkyl generally refers to a non-aromatic straight or branched hydrocarbon chain radical consisting solely of carbon and hydrogen atoms, partially or fully saturated, cyclic or acyclic, having from one to fifteen carbon atoms (e.g., C.sub.1-C.sub.18 alkyl). Unless otherwise state, alkyl is saturated or unsaturated (e.g., an alkenyl, which comprises at least one carbon-carbon double bond). Disclosures provided herein of an alkyl are intended to include independent recitations of a saturated alkyl, unless otherwise stated. Alkyl groups described herein are generally monovalent, but may also be divalent (which may also be described herein as alkylene or alkylenyl groups). In certain embodiments, an alkyl comprises one to thirteen carbon atoms (e.g., C.sub.1-C.sub.12 alkyl). In certain embodiments, an alkyl comprises one to eight carbon atoms (e.g., C.sub.1-C.sub.8 alkyl). In other embodiments, an alkyl comprises one to five carbon atoms (e.g., C.sub.1-C.sub.5 alkyl). In other embodiments, an alkyl comprises one to four carbon atoms (e.g., C.sub.1-C.sub.4 alkyl). In other embodiments, an alkyl comprises one to three carbon atoms (e.g., C.sub.1-C.sub.3 alkyl). In other embodiments, an alkyl comprises one to two carbon atoms (e.g., C.sub.1-C.sub.2 alkyl). In other embodiments, an alkyl comprises one carbon atom (e.g., C.sub.1 alkyl). In other embodiments, an alkyl comprises five to fifteen carbon atoms (e.g., C.sub.5-C.sub.15 alkyl). In other embodiments, an alkyl comprises five to eight carbon atoms (e.g., C.sub.5-C.sub.8 alkyl). In other embodiments, an alkyl comprises two to five carbon atoms (e.g., C.sub.2-C.sub.5 alkyl). In other embodiments, an alkyl comprises three to five carbon atoms (e.g., C.sub.3-C.sub.5 alkyl). In other embodiments, the alkyl group is selected from methyl, ethyl, 1-propyl (n-propyl), 1-methylethyl (iso-propyl), 1-butyl (n-butyl), 1-methylpropyl (sec-butyl), 2-methylpropyl (iso-butyl), 1,1-dimethylethyl (tert-butyl), 1-pentyl (n-pentyl). The alkyl is attached to the rest of the molecule by a single bond. In general, alkyl groups are each independently substituted or unsubstituted.

(16) Alkylene or alkylene chain refers to a straight or branched divalent hydrocarbon chain, having from one to twenty carbon atoms, linking the rest of the molecule to a radical group. In some embodiments, the alkylene is CH.sub.2, CH.sub.2CH.sub.2, or CH.sub.2CH.sub.2CH.sub.2. For non-limiting examples, the C.sub.1 alkylene is CH.sub.2; the C.sub.2 alkylene is CH.sub.2CH.sub.2; the C.sub.3 alkylene is CH.sub.2CH.sub.2CH.sub.2, and the like.

(17) The term heteroalkyl refers to an alkyl group in which one or more skeletal atoms of the alkyl are selected from an atom other than carbon, e.g., oxygen, nitrogen (e.g. NH, N(alkyl)-, sulfur, or combinations thereof. A heteroalkyl is attached to the rest of the molecule at a carbon atom of the heteroalkyl. In one aspect, a heteroalkyl is a C.sub.1-C.sub.6 heteroalkyl. Heteroalkyl may include nitriles, amides, esters, ethers, amines, thioethers, thioesters, carbamates, carbonates, polyethers, polyamines, and the like. Heteroalkyl may also include C.sub.1-8 sulfane, such as propyl-.sup.1-sulfane, butyl-.sup.1-sulfane, pentyl-.sup.1-sulfane, hexyl-.sup.1-sulfane, heptyl-.sup.1-sulfane, and the like.

(18) The term haloalkyl refers to an alkyl group wherein at least one, and possibly more, hydrogen atoms have been replaced with a halogen. For example, haloalkyl includes alkyl derivatives, such as CH.sub.2F, CHF.sub.2, CF.sub.3, CF.sub.2CF.sub.3, CF.sub.2CF.sub.2CF.sub.3, and the like. Haloalkyl is non-limiting in terms of number of halogens and carbons. Generally, haloalkyl refers to C.sub.1-C.sub.12 haloalkyl.

(19) Perfluorinated refers to organofluorine compounds without any CH bonds.

(20) Alkoxy refers to a radical bonded through an oxygen atom of the formula-O-alkyl, where alkyl is as defined above. Unless stated otherwise specifically in the specification, an alkoxy group is optionally substituted, as defined above for an alkyl group.

(21) Aryl refers to a radical derived from an aromatic monocyclic or multicyclic hydrocarbon ring system by removing a hydrogen atom from a ring carbon atom. The aromatic monocyclic or multicyclic hydrocarbon ring system contains only hydrogen and carbon from five to eighteen carbon atoms, where at least one of the rings in the ring system is fully unsaturated, i.e., it contains a cyclic, delocalized (4n+2) -electron system in accordance with the Hckel theory. The ring system from which aryl groups are derived include, but are not limited to, groups such as benzene, fluorene, indane, indene, tetralin and naphthalene.

(22) Halo or halogen refers to bromo, chloro, fluoro or iodo substituents. A haloalkyl refers to an alkyl radical, as described herein, that is substituted with one or more halo radical, such as described above.

(23) Heteroaryl refers to a radical derived from a 3- to 18-membered aromatic ring radical that comprises two to seventeen carbon atoms and from one to six heteroatoms selected from nitrogen, oxygen and sulfur. As used herein, the heteroaryl radical is a monocyclic, bicyclic, tricyclic or tetracyclic ring system, wherein at least one of the rings in the ring system is fully unsaturated, i.e., it contains a cyclic, delocalized (4n+2) -electron system in accordance with the Hckel theory. Heteroaryl includes fused or bridged ring systems. The heteroatom(s) in the heteroaryl radical is optionally oxidized. One or more nitrogen atoms, if present, are optionally quaternized. The heteroaryl is attached to the rest of the molecule through any atom of the ring(s). Examples of heteroaryls include, but are not limited to, azepinyl, acridinyl, benzimidazolyl, benzindolyl, 1,3-benzodioxolyl, benzofuranyl, benzooxazolyl, benzo[d]thiazolyl, benzothiadiazolyl, benzo[b][1,4]dioxepinyl, benzo[b][1,4]oxazinyl, 1,4-benzodioxanyl, benzonaphthofuranyl, benzoxazolyl, benzodioxolyl, benzodioxinyl, benzopyranyl, benzopyranonyl, benzofuranyl, benzofuranonyl, benzothienyl (benzothiophenyl), benzothieno[3,2-d]pyrimidinyl, benzotriazolyl, benzo[4,6]imidazo[1,2-a]pyridinyl, carbazolyl, cinnolinyl, cyclopenta[d]pyrimidinyl, 6,7-dihydro-5H-cyclopenta[4,5]thieno[2,3-d]pyrimidinyl, 5,6-dihydrobenzo[h]quinazolinyl, 5,6-dihydrobenzo[h]cinnolinyl, 6,7-dihydro-5H-benzo[6,7] cyclohepta[1,2-c]pyridazinyl, dibenzofuranyl, dibenzothiophenyl, furanyl, furanonyl, furo[3,2-c]pyridinyl, 5,6,7,8,9,10-hexahydrocycloocta[d]pyrimidinyl, 5,6,7,8,9,10-hexahydrocycloocta[d]pyridazinyl, 5,6,7,8,9,10-hexahydrocycloocta[d]pyridinyl, isothiazolyl, imidazolyl, indazolyl, indolyl, indazolyl, isoindolyl, indolinyl, isoindolinyl, isoquinolyl, indolizinyl, isoxazolyl, 5,8-methano-5,6,7,8-tetrahydroquinazolinyl, naphthyridinyl, 1,6-naphthyridinonyl, oxadiazolyl, 2-oxoazepinyl, oxazolyl, oxiranyl, 5,6,6a, 7,8,9,10,10a-octahydrobenzo[h]quinazolinyl, 1-phenyl-1H-pyrrolyl, phenazinyl, phenothiazinyl, phenoxazinyl, phthalazinyl, pteridinyl, purinyl, pyrrolyl, pyrazolyl, pyrazolo[3,4-d]pyrimidinyl, pyridinyl, pyrido[3,2-d]pyrimidinyl, pyrido[3,4-d]pyrimidinyl, pyrazinyl, pyrimidinyl, pyridazinyl, pyrrolyl, quinazolinyl, quinoxalinyl, quinolinyl, isoquinolinyl, tetrahydroquinolinyl, 5,6,7,8-tetrahydroquinazolinyl, 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidinyl, 6,7,8,9-tetrahydro-5H-cyclohepta[4,5]thieno[2,3-d]pyrimidinyl, 5,6,7,8-tetrahydropyrido[4,5-c]pyridazinyl, thiazolyl, thiadiazolyl, triazolyl, tetrazolyl, triazinyl, thieno[2,3-d]pyrimidinyl, thieno[3,2-d]pyrimidinyl, thieno[2,3-c]pridinyl, and thiophenyl (i.e. thienyl).

(24) In general, optionally substituted groups are each independently substituted or unsubstituted. Each recitation of an optionally substituted group provided herein, unless otherwise stated, includes an independent and explicit recitation of both an unsubstituted group and a substituted group (e.g., substituted in certain embodiments, and unsubstituted in certain other embodiments). Unless otherwise stated, a substituted group provided herein (e.g., substituted alkyl) is substituted by one or more substituent, each substituent being independently selected from the group consisting of halo, cyano, nitro, oxo, thioxo, imino, oximo, trimethylsilanyl, OR.sup.a, SR.sup.a, OC(O)R.sup.a, N(R.sup.a).sub.2, C(O)R.sup.a, C(O)OR.sup.a, C(O)N(R.sup.a).sub.2, N(R.sup.a)C(O)OR.sup.a, OC(O)N(R.sup.a).sub.2, N(R.sup.a)C(O)R.sup.a, N(R.sup.a)S(O).sub.tR.sup.a (where t is 1 or 2), S(O).sub.tOR.sup.a (where t is 1 or 2), S(O).sub.tR.sup.a (where t is 1 or 2) and S(O).sub.tN(R.sup.a).sub.2 (where t is 1 or 2), where each R.sup.a is independently hydrogen, alkyl (e.g., optionally substituted with halogen, hydroxy, methoxy, or trifluoromethyl), fluoroalkyl, carbocyclyl (e.g., optionally substituted with halogen, hydroxy, methoxy, or trifluoromethyl), carbocyclylalkyl (e.g., optionally substituted with halogen, hydroxy, methoxy, or trifluoromethyl), aryl (e.g., optionally substituted with halogen, hydroxy, methoxy, or trifluoromethyl), aralkyl (e.g., optionally substituted with halogen, hydroxy, methoxy, or trifluoromethyl), heterocyclyl (e.g., optionally substituted with halogen, hydroxy, methoxy, or trifluoromethyl), heterocyclylalkyl (e.g., optionally substituted with halogen, hydroxy, methoxy, or trifluoromethyl), heteroaryl (e.g., optionally substituted with halogen, hydroxy, methoxy, or trifluoromethyl), or heteroarylalkyl (e.g., optionally substituted with halogen, hydroxy, methoxy, or trifluoromethyl).

(25) The compounds disclosed herein, in some embodiments, contain one or more asymmetric centers and thus give rise to enantiomers, diastereomers, and other stereoisomeric forms that are defined, in terms of absolute stereochemistry, as (R)- or (S)-. Unless stated otherwise, it is intended that all stereoisomeric forms of the compounds disclosed herein are contemplated by this disclosure. When the compounds described herein contain alkene double bonds, and unless specified otherwise, it is intended that this disclosure includes both E and Z geometric isomers (e.g., cis or trans.) Likewise, all possible isomers, as well as their racemic and optically pure forms, and all tautomeric forms are also intended to be included. The term geometric isomer refers to E or Z geometric isomers (e.g., cis or trans) of an alkene double bond. The term positional isomer refers to structural isomers around a central ring, such as ortho-, meta-, and para-isomers around a benzene ring.

(26) Ferroelectric Nematic (N.sub.F) Host

(27) In some embodiments, the N.sub.F host comprises one or more compounds of Formula (I):

(28) ##STR00052## wherein ring A, ring B, and each ring C are independently an aryl; L.sup.A and each L.sup.B are independently a bond, NN, or

(29) ##STR00053## wherein R.sup.3 and R.sup.4 are each fluoro or R.sup.3 and R.sup.4 form an oxo; R.sup.1 and R.sup.2 are each independently hydrogen, fluoro, or C.sub.1-6 alkoxy; R.sup.A1 is hydrogen, C.sub.1-6 alkyl, C.sub.1-6 alkoxy, C.sub.1-6 heteroalkyl, or

(30) ##STR00054## wherein R.sup.A4 is C.sub.1-6 alkyl; R.sup.A2 and R.sup.A3 are each independently hydrogen, fluoro, or OR, wherein R is C.sub.1-6 alkyl optionally substituted with a C.sub.1-6 alkoxy; R.sup.B1 is fluoro, NO.sub.2, or CN; R.sup.B2 and R.sup.B3 are each independently hydrogen, fluoro, or methoxy; and n is an integer of 1 to 8; provided at least one of L.sup.A and L.sup.B is not a bond.

(31) In some embodiments, ring A, ring B, and each ring C are independently phenyl or naphthyl. In some embodiments, ring A and ring B are phenyl and each ring C is naphthyl. In some embodiments, ring A and ring B are naphthyl and each ring C is phenyl. In some embodiments, ring A, ring B, and each ring C are phenyl. In some embodiments, ring A, ring B, and each ring C are naphthyl.

(32) In some embodiments, the compound of Formula (I) has a structure of Formula (Ia):

(33) ##STR00055##

(34) In some embodiments, the compound of Formula (I) has a structure of Formula (Ib):

(35) ##STR00056##

(36) In some embodiments, the compound of Formula (I) has a structure of Formula (Ib):

(37) ##STR00057##

(38) In some embodiments, L.sup.A and each L.sup.B are

(39) ##STR00058##
wherein R.sup.3 and R.sup.4 are each fluoro or R.sup.3 and R.sup.4 form an oxo. In some embodiments, L.sup.A and each L.sup.B are

(40) ##STR00059##
In some embodiments, L.sup.A is a bond and each L.sup.B is

(41) ##STR00060##
In some embodiments, L.sup.A is

(42) ##STR00061##
and each L.sup.B is a bond. In some embodiments, L.sup.A is a bond and L.sup.B is CF.sub.2O. In some embodiments, L.sup.A is CF.sub.2O and each L.sup.B is a bond. In some embodiments, L.sup.A and each L.sup.B are CF.sub.2O. In some embodiments, L.sup.A is

(43) ##STR00062##
and each L.sup.B is a bond. In some embodiments, L.sup.A is a bond and L.sup.B is

(44) ##STR00063##
In some embodiments, L.sup.A is

(45) ##STR00064##
and each L.sup.B is NN. In some embodiments, L.sup.A is NN and each L.sup.B is

(46) ##STR00065##
In some embodiments, L.sup.A and each L.sup.B are NN.

(47) In some embodiments, R.sup.1 and R.sup.2 are each hydrogen. In some embodiments, R.sup.1 and R.sup.2 are each fluoro. In some embodiments, R.sup.1 is hydrogen and R.sup.2 is C.sub.1-6 alkoxy. In some embodiments, R.sup.1 is hydrogen and R.sup.2 is methoxy, ethoxy, n-propoxy, or n-butoxy. In some embodiments, R.sup.1 is hydrogen and R.sup.2 is fluoro.

(48) In some embodiments,

(49) ##STR00066##
R.sup.A1 is C.sub.1-6 alkyl or

(50) ##STR00067##
wherein R.sup.X is C.sub.1-6 alkyl and R.sup.Y is C.sub.1-6 alkyl optionally substituted with methoxy.

(51) In some embodiments,

(52) ##STR00068##
wherein R.sup.A1 is methoxy. In some embodiments,

(53) ##STR00069##
and R.sup.X is methyl or ethyl, and R.sup.Y is methyl, ethyl, n-propyl, or methoxyethyl. In some embodiments,

(54) ##STR00070##
R.sup.A1 is C.sub.1-6 alkyl,

(55) ##STR00071##
In some embodiments, R.sup.A1 is C.sub.1-6 alkyl. In some embodiments, R.sup.A1 is methyl, ethyl, n-propyl, n-butyl, n-pentyl, or n-hexyl. In some embodiments, R.sup.A1 is n-propyl. In some embodiments, R.sup.A1 is

(56) ##STR00072##
In some embodiments, R.sup.A1 is

(57) ##STR00073##
In some embodiments, R.sup.A1 is

(58) ##STR00074##

(59) In certain embodiments,

(60) ##STR00075##
R.sup.A1 is hydrogen, C.sub.1-6 alkyl, C.sub.1-6 alkoxy, C.sub.1-6 heteroalkyl, or

(61) ##STR00076##
and R.sup.A4 is C.sub.1-6 alkyl, R.sup.Y is C.sub.1-6 alkyl optionally substituted with a C.sub.1-6 alkoxy.

(62) In some embodiments,

(63) ##STR00077##
and R.sup.A1 is C.sub.1-6 alkyl, C.sub.1-6 alkoxy, or C.sub.1-6 heteroalkyl. In some embodiments, R.sup.A1 is C.sub.1-6 alkyl, O(C.sub.1-6 alkyl), or N(C.sub.1-6 alkyl) (C.sub.1-6 alkyl). In some embodiments, R.sup.A1 is N(C.sub.1-6 alkyl) (C.sub.1-6 alkyl). In some embodiments, R.sup.A1 is-N(Me).sub.2. In some embodiments, R.sup.A1 is N(Et).sub.2.

(64) In some embodiments,

(65) ##STR00078##
R.sup.A1 is C.sub.1-6 alkyl or

(66) ##STR00079##
wherein R.sup.X is C.sub.1-6 alkyl and R.sup.Y is C.sub.1-6 alkyl optionally substituted with methoxy.

(67) In some embodiments,

(68) ##STR00080##
wherein R.sup.A1 is methoxy. In some embodiments,

(69) ##STR00081##
and R.sup.X is methyl or ethyl, and R.sup.Y is methyl, ethyl, n-propyl, or methoxyethyl. In some embodiments,

(70) ##STR00082##
R.sup.A1 is C.sub.1-6 alkyl,

(71) ##STR00083##
In some embodiments, R.sup.A1 is C.sub.1-6 alkyl. In some embodiments, R.sup.A1 is methyl, ethyl, n-propyl, n-butyl, n-pentyl, or n-hexyl. In some embodiments, R.sup.A1 is n-propyl. In some embodiments,

(72) ##STR00084##
In some embodiments,

(73) ##STR00085##
In some embodiments, R.sup.A1 is

(74) ##STR00086##
In some embodiments, R.sup.A1 is

(75) ##STR00087##

(76) In some embodiments,

(77) ##STR00088##
wherein R.sup.B2 is hydrogen or fluoro, and R.sup.B1 is CN or fluoro. In some embodiments,

(78) ##STR00089##
wherein R.sup.B2 is hydrogen or fluoro. In some embodiments, R.sup.B2 is hydrogen. In some embodiments, R.sup.B2 is fluoro. In some embodiments,

(79) ##STR00090##
wherein R.sup.B1 is CN or fluoro. In some embodiments, R.sup.B1 is CN. In some embodiments, R.sup.B1 is fluoro.

(80) In some embodiments,

(81) ##STR00091##
In some embodiments,

(82) ##STR00092##
In some embodiments,

(83) ##STR00093##
In one embodiment,

(84) ##STR00094##
In another embodiment,

(85) ##STR00095##

(86) In some embodiments, R.sup.1 and R.sup.2 are each independently hydrogen or C.sub.1-6 alkoxy. In some embodiments, R.sup.1 and R.sup.2 are each independently hydrogen, methoxy, ethoxy, n-propoxy, i-propoxy, n-butoxy, i-butoxy, n-pentoxy, or i-pentoxy. In some embodiments, R.sup.1 and R.sup.2 are hydrogen. In some embodiments, R.sup.1 is hydrogen, and R.sup.2 is methoxy, ethoxy, n-propoxy, i-propoxy, n-butoxy, i-butoxy, n-pentoxy, or i-pentoxy. In some embodiments, R.sup.1 is hydrogen, and R.sup.2 is methoxy, ethoxy, or n-propoxy. In one embodiment, R.sup.1 is hydrogen, and R.sup.2 is methoxy. In another embodiment, R.sup.1 is hydrogen, and R.sup.2 is ethoxy. In another embodiment, R.sup.1 is hydrogen, and R.sup.2 is n-propoxy.

(87) In some embodiments, R.sup.1 and R.sup.2 are fluoro. In some embodiments, R.sup.1 is hydrogen and R.sup.2 is fluoro.

(88) In some embodiments,

(89) ##STR00096##

(90) In some embodiments,

(91) ##STR00097##

(92) In one embodiment,

(93) ##STR00098##

(94) In some embodiments, n is an integer of 1 to 8. In some embodiments, n is an integer of 1 to 7. In some embodiments, n is an integer of 1 to 6. In some embodiments, n is an integer of 1 to 5. In some embodiments, n is an integer of 1 to 4. In some embodiments, n is an integer of 1 to 3. In some embodiments, n is an integer of 1 to 2. In some embodiments, n is an integer of 1, 2, 3, 4, 5, 6, 7, or 8. In one embodiment, n is 1. In another embodiment, n is 2. In yet another embodiment, n is 3. In yet another embodiment, n is 4. In yet another embodiment, n is 5. In yet another embodiment, n is 6. In yet another embodiment, n is 7.

(95) In some embodiments, the compound of Formula (I) is selected from the group consisting of:

(96) ##STR00099## ##STR00100## ##STR00101##

(97) In some embodiments, the N.sub.F host comprising a structure of:

(98) ##STR00102##

(99) In some embodiments, the N.sub.F host is a polymer.

(100) In some embodiments, the N.sub.F host is a polymer having a recurring unit of Formula (II):

(101) ##STR00103## wherein ring A, ring B, and each ring C are independently an aryl; L.sup.A and each L.sup.B are independently a bond, NN, or

(102) ##STR00104## wherein R.sup.3 and R.sup.4 are each fluoro or R.sup.3 and R.sup.4 form an oxo; R.sup.1 and R.sup.2 are each independently hydrogen, fluoro, or C.sub.1-4 alkoxy; R.sup.A1 is hydrogen, C.sub.1-6 alkyl, C.sub.1-6 alkoxy, C.sub.1-6 heteroalkyl, or

(103) ##STR00105##
wherein R.sup.A4 is C.sub.1-6 alkyl; R.sup.A2 and R.sup.A3 are each independently hydrogen, fluoro, or OR, wherein R is C.sub.1-6 alkyl optionally substituted with a C.sub.1-6 alkoxy; R.sup.B1 is fluoro, NO.sub.2, or CN; R.sup.B2 and R.sup.B3 are each independently hydrogen, fluoro, or methoxy; n is an integer of 1 to 8; x is an integer of 1 to 100; at least one of L.sup.A and L.sup.B is not a bond; and X is O or NR.sup.N, wherein R.sup.N is hydrogen, OH, benzyl, or C.sub.1-6 alkyl; and m is an integer of 1 to 30.

(104) In some embodiments, X is O or NR.sup.N, wherein R.sup.N is hydrogen, OH, benzyl, or C.sub.1-6 alkyl. In some embodiments, X is O. In some embodiments, X is O or NR.sup.N. In some embodiments, R.sup.N is hydrogen, OH, benzyl, or C.sub.1-6 alkyl. In some embodiments, R.sup.N is hydrogen, methyl or ethyl. In some embodiments, R.sup.N is hydrogen. In some embodiments, R.sup.N is methyl. In some embodiments, X is O, NH, or NMe. In some embodiments, X is O or NH. In some embodiments, X is NH.

(105) In some embodiments, m is an integer of 1 to 30. In some embodiments, m is an integer of 1 to 25. In some embodiments, m is an integer of 1 to 20. In some embodiments, m is an integer of 1 to 15. In some embodiments, m is an integer of 1 to 10. In some embodiments, m is an integer of 1 to 9. In some embodiments, m is an integer of 1 to 8. In some embodiments, m is an integer of 1 to 7. In some embodiments, m is an integer of 1 to 6. In some embodiments, m is an integer of 1 to 6. In some embodiments, m is an integer of 1 to 5. In some embodiments, m is an integer of 1 to 4. In some embodiments, m is an integer of 1 to 3. In some embodiments, m is 1 or 2. In some embodiments, m is 1. In some embodiments, m is 2. In some embodiments, m is 3. In some embodiments, m is 4. In some embodiments, m is 5. In some embodiments, m is 6. In some embodiments, m is 7. In some embodiments, m is 8. In some embodiments, m is 9.

(106) In some embodiments, n is an integer of 1 to 8. In some embodiments, n is an integer of 1 to 7. In some embodiments, n is an integer of 1 to 6. In some embodiments, n is an integer of 1 to 5. In some embodiments, n is an integer of 1 to 4. In some embodiments, n is an integer of 1 to 3. In some embodiments, n is an integer of 1 to 2. In some embodiments, n is an integer of 1, 2, 3, 4, 5, 6, 7, or 8. In one embodiment, n is 1. In another embodiment, n is 2. In yet another embodiment, n is 3. In yet another embodiment, n is 4. In yet another embodiment, n is 5. In yet another embodiment, n is 6. In yet another embodiment, n is 7.

(107) In some embodiments, m is 6 and X is O.

(108) In some embodiments, x is an integer of 1 to 100. In some embodiments, x is an integer of 1 to 90. In some embodiments, x is an integer of 1 to 80. In some embodiments, x is an integer of 1 to 70. In some embodiments, x is an integer of 1 to 60. In some embodiments, x is an integer of 1 to 50. In some embodiments, x is an integer of 1 to 40. In some embodiments, x is an integer of 1 to 30. In some embodiments, x is an integer of 1 to 20. In some embodiments, x is an integer of 1 to 10. In some embodiments, x is an integer of 1 to 9. In some embodiments, x is an integer of 1 to 8. In some embodiments, x is an integer of 1 to 7. In some embodiments, x is an integer of 1 to 6. In some embodiments, x is an integer of 1 to 5. In some embodiments, x is an integer of 1 to 4. In some embodiments, x is an integer of 1 to 3. In some embodiments, x is an integer of 1 to 2.

(109) In some embodiments, the compound of Formula (II) is a compound having a Formula (IIa):

(110) ##STR00106##

(111) In some embodiments, the compound of Formula (II) is:

(112) ##STR00107##
wherein m is 6.

(113) In some embodiments, the compound of Formula (I) or Formula (II) said molecules having spontaneously formed a ferroelectric polarization density. In some embodiments, the ferroelectric polarization density of the compound of Formula (I) or Formula (II) in the N.sub.F host has a nonzero local unidirectional average orientation of dipoles.

(114) Nonlinear Optical Compound Dopant

(115) In some embodiments, the nonlinear optical dopant having a Formula of: D-B-A, wherein D is a donor moiety, B is a -conjugated bridging moiety, and A is an acceptor moiety.

(116) In some embodiments, in the nonlinear optical compound of Formula D-B-A, D is

(117) ##STR00108##
wherein Ring A is an aryl or heteroaryl ring,
each Y.sup.1 is independently-OH, fluoro, NR.sup.5R.sup.6 or C.sub.1-6 alkoxy, wherein R.sup.5 and R.sup.6 are each independently hydrogen or C.sub.1-6 alkyl; p is an integer of 0 to 5.

(118) In some embodiments, Ring A is an aryl. In some embodiments, Ring A is phenyl. In some embodiments, Ring A is a heteraryl. In some embodiments, Ring A is pyrrole.

(119) In some embodiments, p is 0 to 4. In some embodiments, p is 0 to 3. In some embodiments, p is 0 to 2. In some embodiments, p is 0 or 1.

(120) In some embodiments, when Ring A is phenyl, p is 1. In some embodiments, when Ring A is phenyl, p is 2. In some embodiments, when Ring A is phenyl, p is 3. In some embodiments, when Ring A is pyrrole, p is 0.

(121) In some embodiments, D is selected from:

(122) ##STR00109##
wherein R.sup.5, R.sup.6 and R.sup.9 are each independently hydrogen or C.sub.1-6 alkyl, and R.sup.7 and R.sup.8 are each independently hydrogen or C.sub.1-6 alkoxy.

(123) In some embodiments, D is

(124) ##STR00110##
In some embodiments, Y.sup.1 is OH, fluoro, NR.sup.5R.sup.6 or C.sub.1-6 alkoxy. In some embodiments, Y.sup.1 is OH. In some embodiments, Y.sup.1 is fluoro. In some embodiments, Y.sup.1 is NR.sup.5R.sup.6. In one embodiment, Y.sup.1 NH.sub.2. In some embodiments, Y.sup.1 is C.sub.1-6 alkoxy. In one embodiment, Y.sup.1 methoxy, ethoxy, n-propoxy, or n-butoxy. In one embodiment, Y.sup.1 is methoxy.

(125) In some embodiments, D is

(126) ##STR00111##

(127) In some embodiments, D is

(128) ##STR00112##
In one embodiment, NR.sup.5R.sup.6 is N(CH.sub.3).sub.2. In another embodiment, NR.sup.5R.sup.6 is NH.sub.2.

(129) In some embodiments, D is

(130) ##STR00113##
In some embodiments, D is

(131) ##STR00114##
In some embodiments, D is

(132) ##STR00115##
In some embodiments, D is

(133) ##STR00116##

(134) In some embodiments, in the nonlinear optical compound of Formula D-B-A, D is:

(135) ##STR00117##
wherein R.sup.5, R.sup.6 and R.sup.9 are each independently hydrogen or C.sub.1-6 alkyl, and R.sup.12 is hydrogen, C.sub.1-10 alkyl, C.sub.1-10 heteroalkyl, OC.sub.1-10 alkyl, OC.sub.1-10 heteroalkyl, OC.sub.0-9 alkylene-C.sub.6-10 aryl, OC.sub.0-9 alkylene-C.sub.1-10 heteroaryl, or NR.sup.5R.sup.6.

(136) In some embodiments, in the nonlinear optical compound of Formula D-B-A, D is:

(137) ##STR00118##
wherein R.sup.5, R.sup.6 and R.sup.9 are each independently hydrogen, methyl, or ethyl, and R.sup.12 is hydrogen, C.sub.1-6 alkyl, C.sub.1-6 heteroalkyl, OC.sub.1-6 alkyl, OC.sub.1-6 heteroalkyl, OC.sub.0-6 alkylene-C.sub.6-10 aryl, or OC.sub.0-6 alkylene-C.sub.1-10 heteroaryl.

(138) In some embodiments, in the nonlinear optical compound of Formula D-B-A, D is:

(139) ##STR00119##

(140) In some embodiments, in the nonlinear optical compound of Formula D-B-A, B is selected from: a bond,

(141) ##STR00120## and a combination thereof; wherein each Y is independently N or CH, each Z is independently hydrogen, fluoro, chloro, or C.sub.1-6 alkoxy, and t is an integer of 1 to 4.

(142) In some embodiments, B is a bond. In some embodiments, B is

(143) ##STR00121##
In some embodiments, B is

(144) ##STR00122##
In some embodiments, B is

(145) ##STR00123##
In some embodiments, B is

(146) ##STR00124##
In some embodiments, B is

(147) ##STR00125##
In some embodiments, B is

(148) ##STR00126##
In some embodiments, B is

(149) ##STR00127##
In some embodiments, B is

(150) ##STR00128##

(151) In some embodiments, B comprises two or more of

(152) ##STR00129##

(153) In some embodiments, in the nonlinear optical compound of Formula D-B-A, B is:

(154) ##STR00130##
wherein W is hydrogen, fluoro, chloro, C.sub.1-8 alkyl, C.sub.1-8 alkoxy, C.sub.1-8 heteroalkyl, or C.sub.1-8 haloalkyl, q is an integer of 0 to 5, and t is an integer of 1 to 4.

(155) In some embodiments, q is 1, 2, 3, or 4. In some embodiments, q is 1. In some embodiments, q is 2. In some embodiments, q is 3. In some embodiments, q is 4.

(156) In some embodiments, in the nonlinear optical compound of Formula D-B-A Bis.

(157) ##STR00131##

(158) In some embodiments, each Y is N. In some embodiments, each Y is CH.

(159) In some embodiments, each Z is fluoro. In some embodiments, each Z is hydrogen.

(160) In some embodiments, in the nonlinear optical compound of Formula D-B-A, W is hydrogen, fluoro, chloro, C.sub.1-8 alkyl, C.sub.1-8 alkoxy, C.sub.1-8 heteroalkyl, or C.sub.1-8 haloalkyl. In some embodiments, W is hydrogen. In some embodiments, W is fluoro. In some embodiments, W is chloro. In some embodiments, W is C.sub.1-8 alkyl. In some embodiments, W is C.sub.1-8 alkoxy. In some embodiments, W is C.sub.1-8 heteroalkyl. In some embodiments, W is C.sub.1-8 haloalkyl.

(161) In some embodiments, W is C.sub.1-8 alkyl, C.sub.1-8 heteroalkyl, or C.sub.1-8 haloalkyl. In some embodiments, W is C.sub.1-8 heteroalkyl. In some embodiments, W is S(C.sub.1-8 alkyl), O(C.sub.1-8 alkyl), or N(C.sub.1-8 alkyl)(C.sub.1-8 alkyl). In some embodiments, W is S-(butyl), S-(pentyl), -or S-(hexyl).

(162) In some embodiments, W is C.sub.1-8 sulfanyl. In some embodiments, W is propyl-.sup.1-sulfane. In some embodiments, W is butyl-.sup.1-sulfane. In some embodiments, W is pentyl-.sup.1-sulfane. In some embodiments, W is hexyl-.sup.1-sulfane. In some embodiments, W is heptyl-.sup.1-sulfane.

(163) In some embodiments, t is an integer of 1 to 4. In some embodiments, t is an integer of 1 to 3. In some embodiments, t is an integer of 1 to 2. In one embodiment, tis 1. In another embodiment, t is 2. In another embodiment, t is 3.

(164) In some embodiments, B is selected from: a bond,

(165) ##STR00132##

(166) In some embodiments, B is:

(167) ##STR00133##

(168) In some embodiments, B is selected from:

(169) ##STR00134##

(170) In some embodiments, wherein in the nonlinear optical compound of Formula D-B-A, A is selected from:

(171) ##STR00135##
wherein each Y.sup.2 is hydrogen, fluoro, chloro, NO.sub.2, CN, NCS, SO.sub.2CH.sub.3, or SO.sub.2CF.sub.3; R.sup.7, R.sup.8, and R.sup.9 are each independently hydrogen or CN, and at least one of R.sup.7, R.sup.8, and R.sup.9 is CN.

(172) In some embodiments, wherein in the nonlinear optical compound of Formula D-B-A, A is:

(173) ##STR00136##
wherein each Y.sup.3 is hydrogen, fluoro, chloro, C.sub.1-8 alkyl, C.sub.1-8 alkoxy, C.sub.1-8 heteroalkyl, or C.sub.1-8 haloalkyl; R.sup.7, R.sup.8, and R.sup.9 are each independently hydrogen or CN, and at least one of R.sup.7, R.sup.8, and R.sup.9 is CN.

(174) In some embodiments, A is

(175) ##STR00137##
In some embodiments, each Y.sup.2 is hydrogen or fluoro. In some embodiments, each Y.sup.2 is hydrogen. In some embodiments, each Y.sup.2 is fluoro.

(176) In some embodiments, A is

(177) ##STR00138##
In some embodiments, each Y.sup.2 is hydrogen or fluoro. In some embodiments, each Y.sup.2 is hydrogen. In some embodiments, each Y.sup.2 is fluoro. In some embodiments, R.sup.7 is hydrogen, one or both of R.sup.8 and R.sup.9 are CN. In some embodiments, R.sup.7 is hydrogen, both R.sup.8 and R.sup.9 are CN. In some embodiments, each Y.sup.2 is hydrogen, R.sup.7 is hydrogen, both R.sup.8 and R.sup.9 are CN.

(178) In some embodiments, A is

(179) ##STR00139##
In some embodiments, R.sup.7 is hydrogen, one or both of R.sup.8 and R.sup.9 are CN. In some embodiments, R.sup.7 and R.sup.8 are hydrogen, R.sup.9 is CN. In some embodiments, R.sup.7 and R.sup.9 are hydrogen, R.sup.8 is CN. In some embodiments, R.sup.7 is hydrogen, both R.sup.8 and R.sup.9 are CN.

(180) In some embodiments, A is and

(181) ##STR00140##
In some embodiments, each Y.sup.2 is hydrogen, fluoro or nitro. In some embodiments, each Y.sup.2 is hydrogen. In some embodiments, each Y.sup.2 is fluoro. In some embodiments, each Y.sup.2 is nitro. In some embodiments, A is and

(182) ##STR00141##
In some embodiments, A is and

(183) ##STR00142##
In some embodiments, each Y.sup.2 is hydrogen, fluoro or nitro. In some embodiments, each Y.sup.2 is hydrogen. In some embodiments, each Y.sup.2 is fluoro. In some embodiments, each Y.sup.2 is nitro. In some embodiments, A is

(184) ##STR00143##
In some embodiments, A is selected from:

(185) ##STR00144##

(186) In some embodiments, A is:

(187) ##STR00145##
wherein each Y.sup.3 is independently hydrogen, fluoro, chloro, C.sub.1-8 alkyl, C.sub.1-8 alkoxy, C.sub.1-8 heteroalkyl, or C.sub.1-8 haloalkyl.

(188) In some embodiments, each Y.sup.3 is C.sub.1-8 alkyl, C.sub.1-8 heteroalkyl, or C.sub.1-8 haloalkyl; R.sup.7, R.sup.8, and R.sup.9 are each independently hydrogen or CN, and at least one of R.sup.7, R.sup.8, and R.sup.9 is CN.

(189) In some embodiments, each Y.sup.3 is each independently hydrogen, fluoro, chloro, C.sub.1-8 alkyl, or C.sub.1-8 haloalkyl. In some embodiments, each Y.sup.3 is independently C.sub.1-8 alkoxy, C.sub.1-8 heteroalkyl, or C.sub.1-8 haloalkyl. In some embodiments, each Y.sup.3 is each independently perfluorinated C.sub.1-8 heteroalkyl. In some embodiments, each Y.sup.3 is each independently-CF.sub.3, CF.sub.2CF.sub.3, or CF.sub.2CF.sub.2CF.sub.3. In some embodiments, each Y.sup.3 is each independently-CF.sub.3. In some embodiments, each Y.sup.3 is methyl. In some embodiments, each Y.sup.3 is methyl; R.sup.7, R.sup.8, and R.sup.9 are each independently-CN.

(190) In some embodiments, A is:

(191) ##STR00146##

(192) In some embodiments, the nonlinear optical compound has a zwitterionic ground state.

(193) In some embodiments, in the nonlinear optical compound of Formula D-B-A, D is

(194) ##STR00147##
wherein wherein R.sup.10 and R.sup.11 are each independently hydrogen, fluoro, chloro, or C.sub.1-6 alkyl; R.sup.D is C.sub.1-6 alkyl.

(195) In some embodiments, D is

(196) ##STR00148##
In some embodiments, R.sup.D is methyl, ethyl, n-propyl, n-butyl, n-pentyl, or n-hexyl. In some embodiments, R.sup.D is methyl, ethyl, or n-propyl. In one embodiment, R.sup.D is methyl. In another embodiment, R.sup.D is ethyl. In one preferred embodiment, R.sup.D is n-propyl.

(197) In some embodiments, B is selected from:

(198) ##STR00149##
wherein each Y is independently N or CH, each Z is independently hydrogen, fluoro, chloro, or methyl, and t is an integer of 1 to 4.

(199) In some embodiments, B is selected from:

(200) ##STR00150##

(201) In some embodiments, A is

(202) ##STR00151##
In some embodiments, A is

(203) ##STR00152##
In some embodiments, A is

(204) ##STR00153##

(205) In some embodiments, the nonlinear optical compound is:

(206) ##STR00154##

(207) In some embodiments, the nonlinear optical compound is selected from the group consisting of:

(208) ##STR00155## ##STR00156##
Devices

(209) In another aspect, provided herein are devices comprising a volume comprising the ferroelectric nematic (N.sub.F) compositions described herein, e.g., ferroelectric nematic (N.sub.F) compositions comprising a ferroelectric nematic host and one or more nonlinear optical compounds (chromophores). In some embodiments, the ferroelectric nematic (N.sub.F) compositions spontaneously form a ferroelectric polarization density.

(210) In some embodiments, the device comprises two or more electrodes for application of an electric field. In some embodiments, the electric field causes the ferroelectric polarization density to change in magnitude, thereby producing a change in the electric field. In some embodiments, the polar axis of the ferroelectric polarization density is parallel to the electric field between the electrodes.

(211) Preparation of Compounds

(212) The compounds used in the reactions described herein are made according to organic synthesis techniques known to those skilled in this art, starting from commercially available chemicals and/or from compounds described in the chemical literature. Commercially available chemicals are obtained from standard commercial sources including Acros Organics (Pittsburgh, PA), Aldrich Chemical (Milwaukee, WI, including Sigma Chemical and Fluka), Apin Chemicals Ltd. (Milton Park, UK), Avocado Research (Lancashire, U.K.), BDH Inc. (Toronto, Canada), Bionet (Cornwall, U.K.), Chemservice Inc. (West Chester, PA), Crescent Chemical Co. (Hauppauge, NY), Eastman Organic Chemicals, Eastman Kodak Company (Rochester, NY), Fisher Scientific Co. (Pittsburgh, PA), Fisons Chemicals (Leicestershire, UK), Frontier Scientific (Logan, UT), ICN Biomedicals, Inc. (Costa Mesa, CA), Key Organics (Cornwall, U.K.), Lancaster Synthesis (Windham, NH), Maybridge Chemical Co. Ltd. (Cornwall, U.K.), Parish Chemical Co. (Orem, UT), Pfaltz & Bauer, Inc. (Waterbury, CN), Polyorganix (Houston, TX), Pierce Chemical Co. (Rockford, IL), Riedel de Haen AG (Hanover, Germany), Spectrum Quality Product, Inc. (New Brunswick, NJ), TCI America (Portland, OR), Trans World Chemicals, Inc. (Rockville, MD), and Wako Chemicals USA, Inc. (Richmond, VA).

(213) Specific and analogous reactants are optionally identified through the indices of known chemicals prepared by the Chemical Abstract Service of the American Chemical Society, which are available in most public and university libraries, as well as through on-line databases (contact the American Chemical Society, Washington, D.C. for more details). Chemicals that are known but not commercially available in catalogs are optionally prepared by custom chemical synthesis houses, where many of the standard chemical supply houses (e.g., those listed above) provide custom synthesis services. A reference useful for the preparation and selection of pharmaceutical salts of the benzenesulfonamide derivative compounds described herein is P. H. Stahl & C. G. Wermuth Handbook of Pharmaceutical Salts, Verlag Helvetica Chimica Acta, Zurich, 2002.

EXAMPLES

(214) The examples and embodiments described herein are for illustrative purposes only and various modifications or changes suggested to persons skilled in the art are to be included within the spirit and purview of this application and scope of the appended claims.

Example 1Mixture A and Mixture B

(215) I. Preparation of the Ferroelectric Nematic (N.sub.F) Compositions

(216) Two mixtures, a host mixture (Mixture A) and a host mixture with added dye dopant (Mixture B), were prepared by mixing different host compounds. An azobenzene dye was added to Mixture B. The components in Mixture A and their respective wt % and dipole (D) are summarized in Table 1. The components in Mixture B and their respective wt % and dipole (D) are summarized in Table 2.

(217) TABLE-US-00001 TABLE 1 Mixture A Component Compound # Wt % Dipole (D) 1 25 19 2 25 12.3 3 25 14.4 0 4 25 11.4

(218) TABLE-US-00002 TABLE 2 Mixture B Component Compound # Wt % Dipole (D) 1 20 19 2 20 12.3 3 20 14.4 4 20 11.4 5 20 14.8

(219) The nitro-esters compounds 1 and 4 and the azobenzene dye (compound 5 in Table 2) were synthesized by following the protocols described in literatures including (1) Li et al., Journal of the American Chemical Society 143 (42), 17857-17861 (2021); (2) Li et al., Sci. Adv. 7, eabf5047 (2021); and (3) Datye et al., Teinture et Apprets, 128, 7-31 (1972). Host compounds 2 and 3 were purchased from commercial sources (LCMatter Corp and Ambeed Corp, respectively).

(220) II. Spontaneous Polarization Measurements

(221) Mixture A and Mixture B were filled into ITO-coated liquid crystal cells with a 5 m gap and a parallel buffed polyimide alignment layer (Instec). A 50V triangle wave was applied to the liquid crystal cells loaded with Mixture A or Mixture B at 25 C. and the polarization switching current was measured.

(222) N.sub.F phase transitions were observed in both Mixture A and Mixture B. The N.sub.F phase transition temperatures and the measured spontaneous polarization of Mixture A and Mixture B are summarized in Table 3.

(223) TABLE-US-00003 TABLE 3 Phase Spontaneous transitions Polarization ( C.) (nC/cm{circumflex over ()}2) Mixture A I-94-N-78-N.sub.F 3500 Mixture B I-63-N-45-N.sub.F 3300

(224) Mixture B, which has 20% loading of the azobenzene dye (compound 5) with large hyperpolarizability and a similar dipole as the host mixture (Mixture A), was found to have a N.sub.F phase at room temperature, as evidenced by the polarization switching current measurements. This indicates that the azobenzene dye dopant (compound 5) is highly compatible with the host Mixture A, no disruption of the N.sub.F phase even at a high loading of 20 wt %. The spontaneous polarization measurement of Mixture B was found to be similar to that of the host mixture without the azobenzene dye (Mixture A). The dipole of the azobenzene dye is similar to the dipoles of the N.sub.F host components, based on the dipole values obtained from quantum mechanical calculations (BH&LYP, SVPD, CH.sub.2Cl.sub.2). The observed compatibility of the azobenzene dye dopant with the N.sub.F host mixture is consistent with the predicted polar ordering of the dye dopant in the host mixture.

Example 2Mixture C and Mixture D

(225) I. Preparation of the Ferroelectric Nematic (N.sub.F) Compositions

(226) Two mixtures, a host mixture (Mixture C) and a host mixture with added dye dopant (Mixture D), were prepared by mixing different host compounds. A NLO dye was added to Mixture D. The components in Mixture C and their respective wt % and dipole (D) are summarized in Table 4. The components in Mixture D and their respective wt % and dipole (D) are summarized in Table 5.

(227) TABLE-US-00004 TABLE 4 Mixture C Component Compound # Wt % Dipole (D) 1 26 19 6 16 11.3 7 32 14.6 4 26 11.4

(228) TABLE-US-00005 TABLE 5 Mixture D Component Compound # Wt % Dipole (D) 0 1 25 19 6 15 12.3 7 30 14.4 4 25 11.4 8 5 29.8

(229) The nitro-esters compounds 1 and 4 and the cyano-esters compounds 6 and 7 were synthesized by following the protocols described in literatures including (1) Li et al., Journal of the American Chemical Society 143 (42), 17857-17861 (2021); 92); (2) Li et al., Sci. Adv. 7, eabf5047 (2021); (3) Xianyu, H., Zhao, Y., Gauza, S., Liang, X., & Wu, S.-T. (2008). Liquid Crystals, 35 (9), 1129-1135; (4) Li, Jinxing, et al. Giant 11 (2022): 100109.

(230) II. Spontaneous Polarization Measurements

(231) N.sub.F phase transitions were observed in both Mixture C and Mixture D and are summarized in Table 6.

(232) TABLE-US-00006 TABLE 6 Phase Transition Mixture Temperatures Mixture C I-162-N-132-N.sub.F Mixture D I-148-N-118-N.sub.F

(233) Mixture D, which has 5% loading of the NLO dye (Table 5, compound 8) with large hyperpolarizability and a large molecular dipole, was found to have a N.sub.F phase at room temperature, as evidenced by polarization switching current measurements. This indicates that the NLO dye dopant (compound 8) is highly compatible with the host Mixture C with no disruption of the N.sub.F phase. Strong dichroism was observed (dichroic ratio >6) indicating alignment of the long axis of the NLO dye dopant with the N.sub.F director. Measurement of the unpolarized absorption spectrum of Mixture D in a 2 m parallel buffed sandwich cell is shown in FIG. 1.

(234) III. NLO Dye Synthesis

(235) ##STR00175##

(236) Compound 8 (2-(4-((E)-2-((E)-2-chloro-3-(2-((E)-1,3,3-trimethylindolin-2-ylidene)ethylidene)cyclohex-1-en-1-yl) vinyl)-3-cyano-5,5-dimethylfuran-2 (5H)-ylidene) malononitrile) was synthesized according to literature protocols (Bhuiyan, M. Delower H., et al. Synthesis, linear & non linear optical (NLO) properties of some indoline based chromophores. Dyes and Pigments 89.2 (2011): 177-187.) and added to a 10 mL round-bottom flask equipped with a stir bar (0.104 g, 170 mol). N,N-dimethylformamide (12.4 mg, mol), N-ethyl-N-isopropylpropan-2-amine (26.3 mg, 203 mol), and pentane-1-thiol (21.2 mg, 203 mol) were charged were then added, and the flask heated under argon at 60 C. for 16 h. The resulting material was diluted with 10 mL ethyl acetate, washed 5 with 2 mL brine, dry loaded onto silica, and purified via column chromatography (Hexanes/Ethyl acetate 3:1). Further purification was performed by recrystallization from hot IPA to yield a green powder (18 mg).

(237) IV. Electro-Optic Coefficient (r.sub.33) Measurements

(238) Mixture C and Mixture D were filled into custom made cells comprised of a pyrex substrate with in-plane interdigitated gold electrode with a 50 m gap and a top pyrex cover with a 10 m gap between them. Measurements of the electro-optic coefficient (r.sub.33) of mixture C and mixture D were performed at 1550 nm according literature procedures (A. Nahata, C. Wu and J. T. Yardley, IEEE Transactions on Instrumentation and Measurement, 41, 128-131, (1992)). The results shown in FIG. 2 show a 4 increase in the electro-optic coefficient 133 at 1550 nm with addition of 5% of the NLO dye dopant (compound 8) at frequencies >0.1 MHz where the electro-optic response is dominated by the second order nonlinear optical susceptibility. This shows evidence of polar ordering of the dye occurring spontaneously by mixing with the host mixture.